The authors wish to make the following corrections to this paper [1]: On page 4, the protein band of Actin in HS683 in Figure 2c was wrong. Thus, Figure 2c should be replaced with the following figure (Figure 2).
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Enlarge this image.Figure 2. Effect of DHA on malignant glioma cells apoptosis by regulating AKT axis. The indicated cells were treated with 100 and 200 μM DHA for 48 h. (A) Cells stained with Hoechst 33258 were detected and calculated by fluorescent photomicrographs at 10×; (B) cells were labeled with Annexin V/Propidium Iodide (AnnexinV/PI) and detected by flow cytometry. Values were mean ± SD (n = 3); (C) the proteins associated with AKT/p53/Bcl-2/Bax axis in malignant glioma cells were determined by western blot analysis. The changes of Bax/Bcl-2 ratio were evaluated by western blot analysis. Values were mean ± SD (n = 3). ** p < 0.001, *** p < 0.0001 as compared with negative control cells.
Reference
1. Shao, Y.-Y.; Zhang, T.-L.; Wu, L.-X.; Zou, H.-C.; Li, S.; Huang, J.; Zhou, H.-H. AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells. Int. J. Mol. Sci.; 2017; 18, 350. [DOI: https://dx.doi.org/10.3390/ijms18020350] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28208619]
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details
; Tao-Lan, Zhang 2 ; Lan-Xiang, Wu 1 ; He-Cun Zou 1 ; Li, Shuang 2 ; Huang, Jin 2 ; Hong-Hao, Zhou 1 1 Institute of Life Sciences, Chongqing Medical University, 1 Yixueyuan Road, Yuzhong District, Chongqing 400016, China;
2 Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China;